Viridian Therapeutics, Inc.\DE Annual Return On Equity in % from 2015 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Viridian Therapeutics, Inc.\DE quarterly/annual Return On Equity history and growth rate from 2015 to 2023.
  • Viridian Therapeutics, Inc.\DE Return On Equity for the quarter ending June 30, 2024 was -49.7 %, a 7.78% increase year-over-year.
  • Viridian Therapeutics, Inc.\DE annual Return On Equity for 2023 was -68.3 %, a 46.3% decline from 2022.
  • Viridian Therapeutics, Inc.\DE annual Return On Equity for 2022 was -46.7 %, a 12.2% increase from 2021.
  • Viridian Therapeutics, Inc.\DE annual Return On Equity for 2021 was -53.2 %, a 77.3% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -68.3 -21.6 -46.3% Jan 1, 2023 Dec 31, 2023
2022 -46.7 +6.5 +12.2% Jan 1, 2022 Dec 31, 2022
2021 -53.2 +181 +77.3% Jan 1, 2021 Dec 31, 2021
2020 -234 -86.2 -58.3% Jan 1, 2020 Dec 31, 2020
2019 -148 -96 -185% Jan 1, 2019 Dec 31, 2019
2018 -51.8 +11.8 +18.5% Jan 1, 2018 Dec 31, 2018
2017 -63.6 -226 -139% Jan 1, 2017 Dec 31, 2017
2016 163 -366 -69.2% Jan 1, 2016 Dec 31, 2016
2015 529 Jan 1, 2015 Dec 31, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.